Last week, the Milner Therapeutics Institute were proud to host our 2025 Pitch Day, bringing together a vibrant mix of biotech innovators, investors, and translational science leaders. The event provided a high-energy platform for emerging companies to showcase bold new approaches across oncology, longevity, neuroscience, rare diseases, immunotherapy, and drug discovery.
Each startup had five minutes to pitch, followed by a Q&A session. From novel immunotherapies to AI-driven drug discovery, the afternoon was packed with science-driven innovation and entrepreneurial spirit. This year’s pitching companies demonstrated the power of translational science to shape the future of healthcare, and recordings will soon be available to view on the Pitch Day website.
A huge thank you to our speakers, investors, partners, and Milner Affiliated Companies for making the event a success. Special thanks also to our Pitch Day sponsors: Appleyard Lees, Bailey Fisher, Cancer Research Horizons, Life Science REIT, and Zyme Communications. We look forward to working with these and other companies and investors to advance innovation at the intersection of academia, biotech, and industry.
Photo credit: Eames Photography
